KAPA

Kairos Pharma, Ltd. Common Stock (KAPA)

About Kairos Pharma, Ltd. Common Stock (KAPA)

Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA.

Details

Daily high

$1.23

Daily low

$0.91

Price at open

$0.99

52 Week High

$4.00

52 Week Low

$0.40

Market cap

17.2M

Dividend yield

0.00%

Volume

4.0M

Avg. volume

14.0M

P/E ratio

-4.05

Kairos Pharma, Ltd. Common Stock News